Well-differentiated thyroid carcinoma has a favorable prognosis with a 5-year survival rate of
over 95%. However, the undifferentiated or anaplastic type accounting for< 0.2%, usually in …

Objectives: Anaplastic thyroid carcinoma is associated with a high rate of local recurrence
and poor prognosis. This analysis examines the effects of surgery and radiotherapy on …

Anaplastic thyroid carcinoma is an extremely aggressive solid tumor that resists most
therapeutic efforts and is almost always fatal. It typically arises as a terminal dedifferentiation …

Anaplastic thyroid carcinoma (ATC) is one of the most malignant human neoplasms and has
a grave prognosis. This study gives an update on our experience with this unusual …

Background. Anaplastic thyroid carcinoma is a rare and highly lethal neoplasm. We
investigated whether operations have an impact on the survival of patients who have …

Anaplastic thyroid cancer (ATC) is undoubtedly the thyroid cancer histotype with the poorest
prognosis. The conventional treatment includes surgery, radiotherapy, and conventional …

Anaplastic thyroid cancer (ATC) is an uncommon malignancy of the thyroid. Only 1‐2% of
thyroid cancers are anaplastic, but the disease contributes to 14–50% of the mortality with a …

Background Anaplastic thyroid cancer (ATC) represents a rare, aggressive malignancy. We
analyzed factors predictive for overall survival (OS) and treatment modality utilization …

Globally, thyroid cancer accounts for 2% of all cancer diagnoses, and can be classified as
well-differentiated or undifferentiated. Currently, differentiated thyroid carcinomas have good …

Opinion statement Anaplastic thyroid cancer (ATC) is a rare but very aggressive form of
undifferentiated thyroid cancer. Due to its rapid rate of progression and invasive nature, ATC …